Antiplatelet therapy and risk of adverse cardiovascular events in peripheral artery disease

被引：0

作者：

Kamil, S. ^{[1
]}

Sehested, T. S. G. ^{[2
]}

Blanche, P. ^{[3
]}

Houlind, K. ^{[4
]}

Lassen, J. F. ^{[5
]}

Gislasonl, G. ^{[1
]}

Dorninguez, H. ^{[6
]}

机构：

[1] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark

[2] Roskilde Univ Hosp, Cardiol, Roskilde, Denmark

[3] Univ Copenhagen, Publ Hlth & Biostat, Copenhagen, Denmark

[4] Lillebaelt Hosp, Dept Vasc Surg, Kolding, Denmark

[5] Odense Univ Hosp, Dept Cardiol, Odense, Denmark

[6] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark

来源：

EUROPEAN HEART JOURNAL | 2022年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2321 / 2321

页数：1

共 50 条

[21] Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
Sprenger, Lukas
Mader, Arthur
Larcher, Barbara
Maechler, Maximilian
Vonbank, Alexander
Zanolin-Purin, Daniela
Leiherer, Andreas
Muendlein, Axel
Drexel, Heinz
Saely, Christoph H.
BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (02)
[22] Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease
Golledge, Jonathan
Rowbotham, Sophie
Velu, Ramesh
Quigley, Frank
Jenkins, Jason
Bourke, Michael
Bourke, Bernie
Thanigaimani, Shivshankar
Chan, Dick C.
Watts, Gerald F.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (06):
[23] Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease
Heffron, Sean P.
Ruuth, Maija K.
Xia, Yuhe
Hernandez, Gustavo
Aikas, Lauri
Rodriguez, Crystalann
Oorni, Katariina
Berger, Jeffrey S.
ATHEROSCLEROSIS, 2021, 316 : 53 - 57
[24] Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease
Mittermayer, Friedrich
Krzyzanowska, Katarzyna
Exner, Markus
Mlekusch, Wolfgang
Amighi, Jasmin
Sabeti, Schila
Minar, Erich
Mueller, Markus
Wolzt, Michael
Schillinger, Martin
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (11) : 2536 - 2540
[25] Antithrombotic Therapy and Major Adverse Limb Events in Peripheral Artery Disease A Step Forward
Bonaca, Marc P.
Creager, Mark A.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (20) : 2316 - 2318
[26] Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease
Dick, P
Schillinger, M
Minar, E
Mlekusch, W
Amighi, J
Sabeti, S
Schlager, O
Raith, M
Endler, G
Mannhalter, C
Wagner, O
Exner, M
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (12) : 731 - 737
[27] Risk Factor Control and Major Adverse Cardiovascular Events in Patients With Peripheral Arterial Disease
Parvar, Saman L.
Nicholls, Stephen J.
Lincoff, A. M.
Menon, Venu
Riesmeyer, Jeffrey S.
Ruotolo, Giacomo
Wolski, Kathy
McErlean, Ellen
Nissen, Steven E.
CIRCULATION, 2017, 136
[28] Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease
Cavendish, JJ
Safani, M
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (11) : 1851 - 1855
[29] Type 2 diabetes and risk of cardiovascular events in peripheral artery disease versus coronary artery disease patients
Sprenger, L.
Vonbank, A.
Larcher, B.
Mader, A.
Maechler, M.
Klement, M.
Zanolin-Purin, D.
Leiherer, A.
Muendlein, A.
Drexel, H.
Saely, C. H.
WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S315 - S315
[30] Long term adherence to dual antiplatelet therapy and late adverse cardiovascular events
Bra, Somiot S.
Chirumamilla, Amala
Mehran, Roxana
Syros, George
Singh, Varinder
Singh, Binoy
Taviloglu, Gurkan
Higginbotham, Laura
Stone, Gregg W.
Moses, Jeffrey W.
Leon, Martin B.
Dangas, George
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B88 - B88

← 1 2 3 4 5 →